4th Quarter - Report

CHIESI USA, INC. for CHIESI USA, INC.

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to Therapies for Rare Diseases - Reauthorization of Pediatric Rare PRV, Modifications to IRA, and Access to Home Infusions; H.R. 9474 - Continuing Appropriations and Extension Act, 2025. General healthcare access and innovation matters, and regulatory pathway topics - no specific legislation.

Foreign entity interest: Chiesi Farmaceutici is interested in all issues on line 16.

LobbyistCovered position, as disclosed
GENTRY LASSITER New —
GINA CIOFFI LOUD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9474 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.